Drugs that contain Indinavir Sulfate
1. Crixivan patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6645961 | MERCK SHARP DOHME | Dry granulation formulation for an HIV protease inhibitor |
Mar, 2018
(6 years ago) | |
| US6689761 | MERCK SHARP DOHME | Combination therapy for HIV infection |
Feb, 2021
(3 years ago) | |
Market Authorisation Date: 19 April, 2000
Treatment: Treating hiv infection with indinavir sulfate in combination with antiretroviral agents
Dosage: CAPSULE;ORAL
More Information on Dosage
CRIXIVAN family patents
